Progyny PGNY 深 沪
已收盘 11-14 16:00:00 美东时间
24.55
+0.130
+0.53%
华盛通- 最 高24.72
- 今 开24.07
- 成交量 141.84万股
- 最 低 23.7517
- 昨 收 24.42
- 总市值 21.04亿
- 52周最高 26.76
- 市盈率 静 43.12
- 换手率 0.00%
- 52周最低 13.86
- 委 比 94.76%
- 总股本 8571.80万
- 历史最高 68.32
- 量 比 0.50
- 振 幅 3.97%
- 历史最低 13.29
- 每 手 1
- 风险率 2.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Progyny, Inc. to Present at Jefferies Global Healthcare Conference
Progyny, Inc. announced that its Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the Jefferies Global Healthcare Conference on November 18, 2025. A live audiocast and replay will be available on Progyny’s website. Progyny is a global leader in women’s health and family building solutions, offering comprehensive support and access to specialists to improve clinical outcomes and reduce healthcare costs. Further info...
11-13 17:33
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
11-13 09:58
Progyny upgraded at KeyBanc on catalysts over next year
KeyBanc Capital Markets has upgraded Progyny (PGNY) to overweight from sector weight saying that the women's health benefits company has emerging catalysts over the next 12 months. The bank has a $30 ...
11-13 03:44
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
11-12 11:43
JP Morgan Maintains Neutral on Progyny, Raises Price Target to $26
JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price target from $25 to $26.
11-11 23:59
Progyny Sees Q4 2025 Adj EPS $0.37-$0.40 vs $0.14 Est; Sees Sales $292.700M-$307.700M vs $302.589M Est
Fourth Quarter of 2025 Outlook:Revenue is projected to be $292.7 million to $307.7 million, reflecting a change of (1.9)% to 3.1%; excluding the $35.9 million of revenue in 2024 from the large client who was under a
11-07 05:14
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
Progyny, a global leader in women's health, launched new programs for global employers addressing pregnancy, postpartum, and menopause, available from January 1, 2026. These offerings integrate with their existing fertility solutions, providing a continuum of care supported by localized expertise. Employees gain access to personalized consultations, a knowledge center, country-specific navigator support, and a GDPR-compliant platform. The program...
10-22 13:28
Progyny seesaws amid confusion over impact from Trump’s IVF initiative
Shares of fertility benefits provider Progyny (NASDAQ:PGNY) turned volatile as the Trump administration announced a new initiative to expand access to in vitro fertilization alongside a major drug pri...
10-18 01:11
美银：试管婴儿相关举措对Progyny或存“复杂微妙”影响，该股跌13%
周四，特朗普政府宣布将采取举措扩大试管婴儿（体外受精，IVF）的可及性。过去，该医疗流程的应用受到两方面限制：一是费用高昂，二是部分医疗保险计划可能不涵盖此...
10-17 23:34
